CLIA Services from the Name You Know and Trust

Request a Consultation   

Clinical Services

The Centers for Medicare & Medicaid Services (CMS) regulate all clinical laboratory testing performed on humans in the United States with certification through the Clinical Laboratory Improvement Amendments (CLIA) and accreditation by the College of American Pathologists (CAP).

To support clinical applications, GENEWIZ has established next generation sequencing and Sanger-based CLIA-compliant workflows ensuring high-quality laboratory testing for accurate and consistent sequencing results. Email or call us at 1-877-GENEWIZ (436-3949), Ext. 1 for a technical consultation on our service offerings.


Genomic Tools for Understanding the Molecular Basis of Substance Abuse: Smokescreen Genotyping Platform

Friday, June 14 · 10:00 AM ET & 2:00 PM ET

CLIA Next Generation Sequencing

  • Building

    Whole Exome

    Probe protein-coding regions of the genome at high depth with uniform coverage.

  • Building

    Whole Genome

    Uncover mutations in coding and non-coding regions, including structural and copy number variants.

CLIA Sanger-Based Services

  • Building

    Sanger Sequencing

    CLIA Sanger sequencing is best utilized to elucidate complex regions or to confirm variants uncovered by genome-wide techniques.

  • Building

    Variant Confirmation (PCR + Sanger)

    Reliable method for initial analysis or orthogonal confirmation of next generation sequencing, microarrays, or qPCR results.


  • CMS CLIA Certificate

  • CAP Certificate

  • NJ Clinical Lab License